Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:buprenorphine
|
| gptkbp:administrationFrequency |
twice daily
|
| gptkbp:approvalYear |
2015
|
| gptkbp:ATCCode |
N02AE01
|
| gptkbp:controlledSubstanceSchedule |
gptkb:Schedule_III_(US)
|
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:form |
gptkb:film
buccal film |
| https://www.w3.org/2000/01/rdf-schema#label |
Belbuca
|
| gptkbp:indication |
chronic pain
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
BioDelivery Sciences International
|
| gptkbp:mechanismOfAction |
partial opioid agonist
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:riskFactor |
addiction
respiratory depression abuse potential |
| gptkbp:routeOfAdministration |
buccal
|
| gptkbp:sideEffect |
nausea
vomiting constipation dizziness headache |
| gptkbp:bfsParent |
gptkb:Buprenorphine
gptkb:buprenorphine |
| gptkbp:bfsLayer |
6
|